Short Interest in Nihon Kohden Corporation (OTCMKTS:NHNKY) Declines By 61.7%

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw a large decline in short interest during the month of August. As of August 14th, there was short interest totaling 2,205 shares, a decline of 61.7% from the July 30th total of 5,764 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 18,091 shares, the days-to-cover ratio is currently 0.1 days.

Nihon Kohden Price Performance

OTCMKTS:NHNKY traded up $0.10 on Friday, reaching $9.36. 8,653 shares of the company’s stock were exchanged, compared to its average volume of 8,706. The stock has a fifty day simple moving average of $9.34 and a 200-day simple moving average of $9.53. The firm has a market cap of $1.57 billion, a price-to-earnings ratio of 17.02 and a beta of 0.37. Nihon Kohden has a 52 week low of $8.12 and a 52 week high of $14.21.

Nihon Kohden (OTCMKTS:NHNKY) last issued its earnings results on Thursday, August 6th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.09). Nihon Kohden had a net margin of 5.90% and a return on equity of 9.08%. The business had revenue of $297.47 million for the quarter, compared to the consensus estimate of $299.98 million. As a group, sell-side analysts predict that Nihon Kohden will post 0.6 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, UBS Group downgraded shares of Nihon Kohden from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 12th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock currently has a consensus rating of “Hold”.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.